Evidence map›Paper›PMID 26903619›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Identification of a novel cell death-inducing domain reveals that fungal amyloid-controlled programmed cell death is related to necroptosis.

Asen Daskalov, Birgit Habenstein, Raimon Sabaté, Mélanie Berbon, Denis Martinez, Stéphane Chaignepain, Bénédicte Coulary-Salin, Kay Hofmann, Antoine Loquet, Sven J Saupe

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 134 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Experimental methods for studying amyloid cross-interactions.Protein science : a publication of the Protein Society · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Asen DaskalovInstitut de Biochimie et de Génétique Cellulaire, CNRS, Université de Bordeaux, 33077 Bordeaux, France;
Birgit HabensteinInstitut de Chimie et Biologie des Membranes et des Nanoobjets, CNRS, Université de Bordeaux, 33077 Bordeaux, France;
Raimon SabatéInstitut de Nanociència i Nanotecnologia, Departament Fisicoquímica, Universitat de Barcelona, E-08028 Barcelona, Spain;
Mélanie BerbonInstitut de Chimie et Biologie des Membranes et des Nanoobjets, CNRS, Université de Bordeaux, 33077 Bordeaux, France;
Denis MartinezInstitut de Chimie et Biologie des Membranes et des Nanoobjets, CNRS, Université de Bordeaux, 33077 Bordeaux, France;
Stéphane ChaignepainInstitut de Biochimie et de Génétique Cellulaire, CNRS, Université de Bordeaux, 33077 Bordeaux, France;
Bénédicte Coulary-SalinInstitut de Biochimie et de Génétique Cellulaire, CNRS, Université de Bordeaux, 33077 Bordeaux, France;
Kay HofmannInstitute for Genetics, University of Cologne, D-50674 Cologne, Germany.
Antoine LoquetInstitut de Chimie et Biologie des Membranes et des Nanoobjets, CNRS, Université de Bordeaux, 33077 Bordeaux, France;
Sven J SaupeInstitut de Biochimie et de Génétique Cellulaire, CNRS, Université de Bordeaux, 33077 Bordeaux, France; sven.saupe@ibgc.cnrs.fr.
Centre National de la Recherche Scientifique · FRChimie et Biologie des Membranes et des Nanoobjects · FRInstitut de Biochimie et Génétique Cellulaires · FRUniversitat de Barcelona · ESUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent findings have revealed the role of prion-like mechanisms in the control of host defense and programmed cell death cascades. In fungi, HET-S, a cell death-inducing protein containing a HeLo pore-forming domain, is activated through amyloid templating by a Nod-like receptor (NLR). Here we characterize the HELLP protein behaving analogously to HET-S and bearing a new type of N-terminal cell death-inducing domain termed HeLo-like (HELL) and a C-terminal regulatory amyloid motif known as PP. The gene encoding HELLP is part of a three-gene cluster also encoding a lipase (SBP) and a Nod-like receptor, both of which display the PP motif. The PP motif is similar to the RHIM amyloid motif directing formation of the RIP1/RIP3 necrosome in humans. The C-terminal region of HELLP, HELLP(215-278), encompassing the motif, allows prion propagation and assembles into amyloid fibrils, as demonstrated by X-ray diffraction and FTIR analyses. Solid-state NMR studies reveal a well-ordered local structure of the amyloid core residues and a primary sequence that is almost entirely arranged in a rigid conformation, and confirm a β-sheet structure in an assigned stretch of three amino acids. HELLP is activated by amyloid templating and displays membrane-targeting and cell death-inducing activity. HELLP targets the SBP lipase to the membrane, suggesting a synergy between HELLP and SBP in membrane dismantling. Remarkably, the HeLo-like domain of HELLP is homologous to the pore-forming domain of MLKL, the cell death-execution protein in necroptosis, revealing a transkingdom evolutionary relationship between amyloid-controlled fungal programmed cell death and mammalian necroptosis.

Indexed as

Amino Acid MotifsAmino Acid SequenceAmyloidCell DeathCell MembraneFungal ProteinsLuminescent ProteinsMagnetic Resonance SpectroscopyModels, MolecularMolecular Sequence DataPodosporaPrionsProtein Structure, SecondaryProtein Structure, TertiarySequence Homology, Amino AcidSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAmyloidFungal ProteinsLuminescent ProteinsPrionsamyloidincompatibilitynecroptosisprionprogrammed cell death

Identifiers

PMID26903619
PMCPMC4790977
OpenAlexW2287080039

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.